Skip to content
Tuesday, November 10, 2026
Lebensklang24

Patients Discontinuing Anti-Obesity Medications Put On Weight at a Quadrupled Rate Compared to Dieters

Illustration of medical syringe and scale
Obesity treatment often requires ongoing approaches.

Fresh analysis indicates that individuals who discontinue popular slimming jabs like Wegovy and Mounjaro can put back on reduced body mass far faster than those who halt conventional diet and exercise regimens.

Research printed in a major medical journal points out that while overweight individuals can lose a large proportion of their body weight while using the jabs, the weight comes back at an estimated rate of nearly a kilo each month once they quit.

"Users purchasing these treatments should be aware of the danger of fast rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.

That rate of recovery suggests a reversion to original mass in about one and a half years.

Comparing Therapies

The research, which reviewed 37 of studies involving thousands of patients, compared the effects of the injectable medications with conventional dieting.

The team point out that people who shed pounds through diet and exercise generally experience a slower creep back—around 100 grams monthly—once they finish.

Understanding the Fast Rebound

Experts believe the mode of action of the jabs accounts for the heightened rebound.

GLP-1 drugs imitate a body's own chemical called GLP-1, which moderates appetite.

"Artificially providing GLP-1 concentrations far above than normal could lead to the body to produce less of its own natural hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this GLP-1 'fix' results in appetite is unsuppressed, making binge eating far more likely."

An Ongoing Disease?

Health authorities recommend the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.

Professionals argue that, given the significant potential of relapse, the treatment should be considered life-long.

This view is supported by drug manufacturers, who note that the results "underscore the persistent nature of obesity," akin to managing conditions like high blood pressure.

User Testimonies

People who have stopped the jabs explain a sudden resurgence of cravings.

"It was like a switch flipping and I was suddenly extremely hungry," described one woman.

The struggle is exacerbated if patients have not established permanent dietary or behavioural modifications during treatment.

Widespread Use

Recent estimates indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire remaining high.

  • Adoption is more common among women than males.
  • The 40s and 50s demographic shows the greatest usage rates.
  • A large proportion access the drugs through private healthcare rather than public health services.

Ultimately, experts caution that while GLP-1 drugs are effective tools for weight loss, they are not a standalone solution and lasting health benefits relies on combined behavioural support.

About the author

Kristin Vang

Elena ist eine erfahrene Wellness-Coachin, die sich auf ganzheitliche Gesundheit und persönliche Entwicklung spezialisiert hat.

Lebensklang24

Type to search articles.